Accelerating theory into practice

In the fight against cancer, hope, health and progress are being held back by supply chains. Nusano is working to remove these barriers and usher in a new era in cancer care.

advancing cancer care

Without a reliable supply of medical-grade radioisotopes, pharmaceutical makers and cancer centers cannot design next-generation cancer diagnostics, drugs and treatments. The result is patient care driven by what is accessible, rather than what is possible.

The Nusano production platform combines time-proven technology from universities and world-class research centers with the company’s patented particle acceleration technology.

The result is the first significant advancement in radioisotope production in decades – a platform that’s smaller, safer and more efficient than existing methods, and capable of the simultaneous manufacturing of multiple radioisotopes needed for advanced pharmaceuticals, treatments and procedures.

mighty. small.

Nusano’s patented, breakthrough particle beam technology is capable of generating heavy ions orders of magnitude greater than any existing comparable source.


Nusano produces radioisotopes at scale, providing a much-needed increase in supply for these vital resources in medical diagnostics and therapies


Our flexible production platform allows for the production of otherwise unavailable or unaffordable radioisotopes, opening the door to specialty cancer therapy development


Nusano’s breakthrough technologies allow for the production of up to 12 different kinds of medical radioisotopes in a single production run


Third generation linear accelerator technology consumes less energy to produce the same amount of radioisotopes as existing technologies – all within a footprint that’s 90% smaller than others accelerators

From production To patient

Nusano’s role in the health care ecosystem is as a supplier of medical radioisotopes to drugmakers, hospitals and clinics. With a reliable supply of radioisotopes, these teams can then formulate treatments and next-generation pharmaceuticals needed to advance the fight against cancer.

Image of linear accelerator and resulting isotopes

Nuclear medicine


Radioisotopes are used in “nuclear medicine,” a term which includes radiology practices at most major hospitals. Nuclear medicine is routine throughout the United States and much of the world. Anyone who has ever received an MRI or had their cancer treated with radiation oncology is a beneficiary of the power of nuclear medicine. There are more than 40 million nuclear medicine procedures performed each year around the world.



When injected in very small quantities into a patient, radioisotopes act as tiny tracers or flashlights. This allows tumors to be seen using medical imaging devices, such as MRIs and PET scans. By providing a picture of what’s going on inside the body, radioisotopes help health care professionals diagnose diseases and guide treatment decisions.



 Increasingly, pharmaceutical makers are developing new drugs (radiopharmaceuticals) capable of delivering the cancer-killing power of radioisotopes directly to tumors while leaving the surrounding healthy tissue intact. Like a puzzle piece, these drugs attach only one way – directly to the proteins associated with the cancer – for maximum efficiency.

Diagram: Radiotherapeutics target and eliminate cancer cells with precision. Adapted from National Cancer Institute.

real world

Use cases and studies

This image shows a prostate cancer patient. The spots in the Pre-treatment image are cancerous growths.

To treat this patient’s cancer a radioisotope-based pharmaceutical was administered.

Multiple rounds of treatment (Month 0-4) produced a successful effect. The cancer no longer appeared on image scans by month six. (Image adapted from source)

Source PDF: Hun Yee Tan, Chai Hong Yeong, Yin How Wong, Molly McKenzie, Azahari Kasbollah, Mohamad Nazri Md. Shah, Alan Christopher Perkins, Neutron-activated theranostic radionuclides for nuclear medicine, Nuclear Medicine and Biology, Volumes 90–91, 2020, Pages 55-68,  ISSN 0969-8051, Link.

Learn more about radiopharmaceuticals

Links are provided for educational purposes only and will take you away from our website. No endorsement of Nusano is made by these organizations. 

Dana-Farber Cancer Institute:

What Are Radiopharmaceuticals and How Are They Used in Cancer?

American Cancer Society:

How Radiation Therapy Is Used to Treat Cancer

Cancer Treatment Centers of America:

Radiopharmaceuticals designed to take radiation directly to the cancer


Detailed technical information and validation data is available to qualified investors and research partners. If interested in learning more about the Nusano production platform, please contact us.